Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.82 is 79% below its 5-year average of 3.90, near the low end of its 5-year range (0.82–6.94).
As of the fiscal period ended Tuesday, June 30, 2026. 77.89% below its 12-month average of 3.71.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.82.
CURRENT RATIO
0.82
CURRENT RATIO AVG TTM
3.71
CURRENT RATIO AVG 3Y
4.43
CURRENT RATIO AVG 5Y
3.90
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-77.89%
CURRENT VS 3Y AVG
-81.47%
CURRENT VS 5Y AVG
-78.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.48
median of 699 covered companies
CURRENT VS SECTOR MEDIAN
-76.39%
vs the sector median at left
Korsana Biosciences, Inc.
Market Cap
$146.59M
Current Ratio
0.82
TTM Avg
3.71
3Y Avg
4.43
5Y Avg
3.90
Market Cap
$145.75M
Current Ratio
19.47
TTM Avg
11.39
3Y Avg
11.91
5Y Avg
15.23
Market Cap
$147.54M
Current Ratio
1.23
TTM Avg
1.14
3Y Avg
1.35
5Y Avg
4.96
Market Cap
$150.96M
Current Ratio
2.47
TTM Avg
5.27
3Y Avg
13.16
5Y Avg
16.37
Market Cap
$141.83M
Current Ratio
0.79
TTM Avg
0.57
3Y Avg
0.67
5Y Avg
0.95
Market Cap
$152.63M
Current Ratio
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Korsana Biosciences, Inc. (KRSA) | $146.59M | 0.82 | 3.71 | 4.43 | 3.90 |
| Immuneering Corporation (IMRX)vs › | $145.75M | 19.47 | 11.39 | 11.91 | 15.23 |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $147.54M | 1.23 | 1.14 | 1.35 | 4.96 |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | 0.90 | 1.03 | 0.91 | 1.08 |
| Nyxoah S.A. (NYXH)vs › | $143.10M | 2.38 | 2.90 | 4.31 | 7.34 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $150.96M | 2.47 | 5.27 | 13.16 | 16.37 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $141.83M | 0.79 | 0.57 | 0.67 | 0.95 |
| Codexis, Inc. (CDXS)vs › | $151.93M | 3.06 | 4.00 | 3.48 | 4.36 |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.63M | 15.62 | 10.23 | 11.93 | 11.24 |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 3.96 | 1.88 | 1.73 | 2.58 |
Current Ratio
0.82
Quick Ratio
0.82
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.82 |
| 2026-03-31 | 1.80 |
| 2025-12-31 | 5.15 |
| 2025-09-30 | 5.78 |
| 2025-06-30 | 5.03 |
| 2025-03-31 | 4.21 |
| 2024-12-31 | 5.83 |
| 2024-09-30 | 5.07 |
| 2024-06-30 | 3.68 |
| 2024-03-31 | 4.17 |
| 2023-12-31 | 3.85 |
| 2023-09-30 | 4.21 |
| 2023-06-30 | 1.44 |
| 2023-03-31 | 1.11 |
| 2022-12-31 | 1.94 |
| 2022-09-30 | 2.54 |
| 2022-06-30 | 3.22 |
| 2022-03-31 | 4.51 |
| 2021-12-31 | 5.00 |
| 2021-09-30 | 5.61 |
| 2021-06-30 | 6.94 |
| 2021-03-31 | 3.30 |
| 2020-12-31 | 3.45 |
| 2020-09-30 | 4.31 |
| 2020-06-30 | 3.81 |
| 2020-03-31 | 6.13 |
| 2019-12-31 | 5.55 |
| 2019-09-30 | 6.32 |
| 2019-06-30 | 6.60 |
| 2019-03-31 | 0.05 |
| 2018-12-31 | 0.05 |
| 2018-09-30 | 0.00 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 0.00 |
| 2017-12-31 | 0.00 |
| 2017-09-30 | 0.00 |
